What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Cardiology
His primary areas of investigation include Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Surgery.
His Internal medicine study focuses mostly on Randomized controlled trial, Coronary artery disease, Aspirin, Clopidogrel and Unstable angina.
His studies in Cardiology integrate themes in fields like Stent and Coronary stent.
His Myocardial infarction research is multidisciplinary, relying on both Electrocardiography, Angioplasty and Heparin.
His work carried out in the field of Percutaneous coronary intervention brings together such families of science as Anesthesia and Conventional PCI.
His study in Surgery is interdisciplinary in nature, drawing from both Stroke and Stenosis, Valve replacement.
His most cited work include:
- ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina) (4506 citations)
- Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. (3807 citations)
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents (1194 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Cardiology, Myocardial infarction, Surgery and Percutaneous coronary intervention.
His work in Randomized controlled trial, Angioplasty, Coronary artery disease, Clinical trial and Aspirin are all subfields of Internal medicine research.
Dean J. Kereiakes interconnects Coronary stent and Hazard ratio in the investigation of issues within Cardiology.
His Myocardial infarction research includes elements of Stroke, Thrombosis and Clinical endpoint.
In the subject of general Surgery, his work in Stent and Lesion is often linked to In patient, thereby combining diverse domains of study.
The various areas that he examines in his Percutaneous coronary intervention study include Platelet aggregation inhibitor, Anesthesia, Conventional PCI and Percutaneous.
He most often published in these fields:
- Internal medicine (60.18%)
- Cardiology (51.15%)
- Myocardial infarction (29.56%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (60.18%)
- Cardiology (51.15%)
- Randomized controlled trial (18.41%)
In recent papers he was focusing on the following fields of study:
Dean J. Kereiakes spends much of his time researching Internal medicine, Cardiology, Randomized controlled trial, Surgery and Myocardial infarction.
His Cardiology study frequently links to other fields, such as Clinical trial.
The concepts of his Randomized controlled trial study are interwoven with issues in Stroke, Angina, Framingham Risk Score and Target lesion.
Biomedical engineering, Bioresorbable vascular scaffold, Bioresorbable scaffold and Stent thrombosis is closely connected to Everolimus in his research, which is encompassed under the umbrella topic of Surgery.
His work on Thienopyridine as part of general Myocardial infarction study is frequently linked to Alirocumab, bridging the gap between disciplines.
Dean J. Kereiakes has researched Percutaneous coronary intervention in several fields, including Aspirin and MEDLINE.
Between 2017 and 2021, his most popular works were:
- Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement. (115 citations)
- Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial. (83 citations)
- Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial (55 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Surgery
Dean J. Kereiakes mostly deals with Internal medicine, Cardiology, Randomized controlled trial, Stroke and Percutaneous coronary intervention.
His Internal medicine study integrates concerns from other disciplines, such as Lorcaserin and Prediabetes.
His research in Cardiology focuses on subjects like Lithotripsy, which are connected to Calcification.
His Randomized controlled trial study is focused on Surgery in general.
Dean J. Kereiakes has included themes like Stent, Bioabsorbable polymer and Conventional PCI in his Percutaneous coronary intervention study.
The Myocardial infarction study combines topics in areas such as Coronary artery disease, Clinical endpoint and Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
